FDA Inspection 1265683 — CSL Plasma Inc.

CSL Plasma Inc. — FEI 1930460

The FDA completed an inspection of CSL Plasma Inc. on March 21, 2025 in Kansas City, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 21, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Kansas City, MO (United States)